Patient Reported Outcomes Registry in Patient With Cancer Cachexia
NCT02983500 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 253
Last updated 2020-08-07
Summary
Evaluation of patient reported outcomes (PRO) with tumor cachexia in a real life setting.
Conditions
- Metastatic Pancreatic Cancer
- NSCLC, Metastatic
Sponsors & Collaborators
-
Chugai Pharma Europe Ltd.
collaborator INDUSTRY -
iOMEDICO AG
lead INDUSTRY
Principal Investigators
-
Manfred Welslau, MD · Medical practise for oncology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-28
- Primary Completion
- 2019-07-24
- Completion
- 2019-07-24
Countries
- Germany
More Related Trials
-
Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas Cancer
NCT02921646 ·Status: TERMINATED ·Phase: NA
-
The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response
NCT06050395 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
NCT05356039 ·Status: RECRUITING
-
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer
NCT05692323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
NCT05262855 ·Status: COMPLETED ·Phase: PHASE2
-
Translational Research on Locally Advanced Pancreatic Adenocarcinoma
NCT03009253 ·Status: UNKNOWN ·Phase: NA
-
Changes in Muscle Tissue in Patients With Pancreatic Cancer
NCT00369460 ·Status: COMPLETED
-
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
NCT02580422 ·Status: TERMINATED
-
Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
NCT02342847 ·Status: COMPLETED
-
Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients
NCT02400398 ·Status: COMPLETED
-
Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study
NCT07173374 ·Status: SUSPENDED ·Phase: PHASE1
-
Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses
NCT04603586 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
NCT02459652 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
NCT02243358 ·Status: COMPLETED ·Phase: PHASE2
-
Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC
NCT04855331 ·Status: RECRUITING ·Phase: NA
-
Identify microRNAs in Cachexia in Pancreatic Carcinoma
NCT05275075 ·Status: RECRUITING
-
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
NCT06129812 ·Status: COMPLETED
-
Microbiota and Pancreatic Cancer Cachexia
NCT05606523 ·Status: RECRUITING
-
Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC
NCT06346808 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
NCT06989437 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions
NCT06106568 ·Status: COMPLETED
-
A Study of Pancreatic Cancer in Xenografts From Liver Metastases
NCT01774643 ·Status: COMPLETED
-
Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer
NCT04931394 ·Status: UNKNOWN ·Phase: PHASE3
-
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer
NCT04975516 ·Status: TERMINATED ·Phase: PHASE2
-
Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer
NCT02405585 ·Status: TERMINATED ·Phase: PHASE2